Fleecy amyloid deposits in the internal layers of the human entorhinal cortex are comprised of N-terminal truncated fragments of aβ

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 2, 1999, Pages 210-216

  Thal, Dietmar Rudolf ^a   Sassin, Irena ^a   Schultz, Christian ^a   Haass, Christian ^b   Braak, Eva ^a   Braak, Heiko ^a  

^a GOETHE UNIVERSITY   (Germany)

^b Ctrl Institute of Mental Health J5   (Germany)

Author keywords

Alzheimer disease; Entorhinal cortex; P3 peptide; Pigmentoarchitectonic; amyloid

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ARTICLE; AUTOPSY; CLINICAL ARTICLE; ENTORHINAL CORTEX; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0033033228     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199902000-00010     Document Type: Article

References (25)

1. Esiri MM, Hyman BT, Beyreuther K, Masters CL. Ageing and dementia. In: Graham DI. Lantos PL eds. Greenfields Neuropathology Vol. 2, 6th edition. London: Arnold, 1996:153-233
2. Anderton BH. Expression and processing of pathologic proteins in Alzheimer's disease. Hippocampus 1993:3(suppl.):227-38
3. Busciglio J, Gabuzda DH, Matsudaira P, Yankner BA. Generation of β-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc Natl Acad Sci USA 1993;90:2092-96
4. Haass C, Koo EH, Mellon A, Hung AY, Selkoe DJ. Targeting of cell-surface β-amyloid precursor protein to lysosomes: Alternative processing into amyloid-bearing fragments. Nature 1992;357:500-503
5. Selkoe DJ. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Ann Rev Cell Biol 1994;10: 373-403
6. Shoji M, Golde TE, Ghiso J, et al. Production of Alzheimer amyloid β protein by normal proteolytic processing. Science 1995;258: 126-29
7. Weidemann A, König G, Bunke D, et al. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 1989;57:115-26
8. Dickson DW. The pathogenesis of senile plaques. J Neuropathol Exp Neurol 1997;56:321-39
9. Gowing E, Roher AE. Woods AS, et al. Chemical characterization of Aβ 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer's disease. J Biol Chem 1994;269:10987-90
10. Higgins LS, Murphy Jr GM, Forno LS, Catalano R, Cordell B. p3 β-amyloid peptide has a unique and potentially pathogenetic immunocytochemical profile in Alzheimer's disease brain. Am J Pathol 1996;149:585-96
11. Griffin WST, Sheng JG, Roberts GW, Mrak RE. Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution. J Neuropathol Exp Neurol 1995;54:276-81
12. Iwatsubo T, Saido TC, Mann DMA, Lee VM-Y, Trojanowski JQ. Full length amyloid-β(1-42(43)) and amino-terminally modified and truncated amyloid-β42(43) deposit in diffuse plaques. Am J Pathol 1996;149:1823-30
13. Tekirian TL, Saido TC, Markesbery WR, Russell MJ, Wekstein DR, Patel E, Geddes JW. N-terminal heterogeneity of parenchymal and cerebrovascular Aβ deposits. J Neuropathol Exp Neurol 1998;57: 76-94
14. Kida E, Wisniewski KE, Wisniewski HM. Early amyloid-β deposits show different immunoreactivity to the amino- and carboxy-terminal regions of β-peptide in Alzheimer's disease and Down's syndrome brain. Neurosci Lett 1995;193:105-8
15. Braak H, Braak E. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1991;1: 213-16
16. Rose M. Cytoarchitektonik und Myeloarchitektonik der Großhirnrinde. In: Bumke O, Foerster O. eds. Handbuch der Neurologie. Berlin: Springer-Verlag, 1935:588-778
17. Braak H, Braak E. The human entorhinal cortex: Normal morphology and lamina-specific pathology in various diseases. Neurosci Res 1992;15:6-31
18. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59
19. Wild-Bode C, Yamazaki T, Capell A, et al. Intracellular generation and accumulation of amyloid β-peptide terminating at amino acid 42. J Biol Chem 1997;272:16085-88
20. Akiyama H, Schwab C, Kondo H, et al. Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of β-amyloid protein. Neurosci Lett 1996;206: 169-72
21. Hsu S-M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80
22. Carter DB, Chou K-C. A model for structure-dependent binding of Congo red to Alzheimer β-amyloid fibrils. Neurobiol Aging 1998; 19:37-40
23. Jarrett JT, Costa PR, Griffin RG, Lansbury PT. Models of the β-protein C-terminus: Differences in amyloid structure may lead to segregation of "long" and "short" fibrils. J Am Chem Soc 1994; 116:9741-42
24. Roher AE, Palmer KC, Yurewicz EC, Ball MJ, Greenberg BD. Morphological and biochemical analyses of amyloid plaque core proteins purified from Alzheimer disease brain tissue. J Neurochem 1993;61:1916-26
25. Harper JD, Lieber CM, Lansbury PT. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-β protein. Chem Biol 1997;4:951-59